Hemophagocytic lymphohistiocytosis (HLH) is a rare and often aggressive syndrome of hyperactive inflammation with up to a 40% mortality rate. Scientists at St. Jude Children's Research Hospital have shown that a drug inhibiting ...
Mar 6, 2024
0
0
Few standard treatments have been available for advanced myelofibrosis, a bone marrow disorder characterized by excessive scar tissue that disrupts the normal production of blood cells
Dec 11, 2023
0
0
For patients with nonsegmental vitiligo, continued improvement in seen during a long-term extension of ruxolitinib treatment, according to study presented at the annual meeting of the American Academy of Dermatology, held ...
Mar 28, 2023
0
5
Sarah Hayden owns a lot of turtlenecks. She also has chunky necklaces and tons of makeup—anything to cover up the blotchy white skin on her face, neck, hands and knees.
Oct 21, 2022
0
2
For patients with vitiligo, ruxolitinib cream results in greater repigmentation of lesions compared with vehicle control, according to a study published online Oct. 20 in the New England Journal of Medicine.
Oct 20, 2022
0
5
Over the last decade, immune checkpoint blockers, or ICBs, have revolutionized treatment for various advanced cancers, including melanoma, the most aggressive skin cancer that was considered largely incurable not long ago. ...
Sep 19, 2022
0
67
Scientists at St. Jude Children's Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic leukemia in mice with a genetic mutation that increases the risk of childhood cancer.
Feb 7, 2022
0
7
Australian scientists have found what could prove to be a new and effective way to treat a particularly aggressive blood cancer in children.
May 28, 2021
0
4
A transgenic mouse developed at Cincinnati Children's to model the deadly childhood immune disease HLH (hemophagocytic lymphohistiocytosis) may play a key role in saving lives during the COVID-19 virus pandemic.
May 28, 2020
0
145
A popular cancer drug is associated with significant weight gain and increased systolic blood pressure, researchers from the Icahn School of Medicine at Mount Sinai report in a study published in Scientific Reports in November.
Nov 12, 2019
0
31
